Jeffrey brings more than 25 years of finance and capital markets experience at life sciences and medical technology companies. He most recently served as Chief Financial Officer at Atalanta Therapeutics, where he played an instrumental role in the company’s $97 million Series B financing. Prior to Atalanta he was Chief Financial Officer, Senior Vice President, and Treasurer at Axial Therapeutics, where he led teams across finance, accounting and tax, HR, among other efforts; facilitated the company’s successful Series B and Series C financings; and developed corporate and commercial strategy. Jeffrey has also served as CFO at Nasdaq-listed companies Juniper Pharmaceuticals, OvaScience, TransMedics Group, and Lantheus Medical Imaging. He began his career at PwC as a certified public accountant. Jeffrey holds a B.S. in business administration from Georgetown University.
